Navigation Links
QIAvac 24 Plus

ProductsQIAvac 24 Plus
Company QIAGEN
Item QIAvac 24 Plus
Features Inquire
Description The new QIAvac 24 Plus vacuum manifold allows processing of up to 24 spin columns in parallel, eliminating the tedious loading and unloading of spin columns into and out of a centrifuge.

The new QIAvac 24 Plus offers:

  • Time savings rapid vacuum-driven purification and cleanup of plasmid or genomic DNA, PCR products, and RNA
  • Convenience minimal hands-on-time
  • Flexibility process up to 24 columns in parallel
  • Versatility suitable for use with QIAprep, QIAquick, MinElute, QIAamp, and RNeasy spin columns
Info QIAGEN
Customer Service: (800) 426-8157
Web site: http://www1.qiagen.com

Related medicine products :

1. QIAvac Connecting System
2. QIAvac Luer Adapter Set
3. QIAvac Plate Holder
4. QIAvac 6S
5. QIAvac 96
6. QIAvac 24
7. QIAvac Multiwell
TAG: QIAvac Plus
...rgery, and the accompanying need for patient hemod...aft be developed. Grafts must not only be strong, ...ying sizes and configurations for improved vascula...e prosthetic of choice among vascular surgeons wor...
...t vascular graft offering from W. L. Gore & Associ...ore than two decades, redefines graft performance ... can lead to complications post-surgery. This new ... without the rings. Employing a patented, unibody...
...t vascular graft offering from W. L. Gore & Associ...ore than two decades, redefines graft performance ... can lead to complications post-surgery. This new ... without the rings. Employing a patented, unibody...
Vikingselect™ Intra-Operative Monitoring (IOM).
Medicine Products:
(Date:9/8/2008)... LegalView recently reported o...proton pump inhibitor (PPI) drugs. The drugs are u...omach as well as other stomach/intestinal issues i...GERD), dyspepsia, some forms of stomach infections... Denver, CO (PRWEB) September 8, 2008 -- ...
(Date:9/7/2008)...ew analysis reveals that fewer than half of older ...r receive the recommended screening schedule to de...g in the October 15, 2008 issue of CANCER , a pee... indicates poor compliance to recommended monitori...vival. , Patients who undergo potentially curati...
(Date:9/7/2008)...rican Lung Association Calls Upon Students and Uni...allenge and End the Addiction to Big Tobacco, WAS...e students are,falling victim to aggressive tobacc...ue to smoke, according to a new report released to... provides a comprehensive overview of the current ...
(Date:9/5/2008)...ARRISBURG, Pa., Sept. 5 /PRNewswire-USNewswire/ --...ssued a proclamation acknowledging Sept. 11 as,Ame...h of Pennsylvania and The American Red Cross ask d...ation of those who lost their,lives on 9/11 and to...od,donation can save up to three lives., "We all ...
Breaking Medicine News(10 mins):Health News:LegalView Warns Proton Pump Inhibitor Patients of Potential Bone Fracture Risk Associated with Drug 2Health News:LegalView Warns Proton Pump Inhibitor Patients of Potential Bone Fracture Risk Associated with Drug 3Health News:LegalView Warns Proton Pump Inhibitor Patients of Potential Bone Fracture Risk Associated with Drug 4Health News:Many colorectal cancer survivors do not receive recommended follow-up care 2Health News:Big Tobacco's Grip on Colleges and Students Loosens, But Still Holding Strong: New Report Examines Trends on Campuses 2Health News:Big Tobacco's Grip on Colleges and Students Loosens, But Still Holding Strong: New Report Examines Trends on Campuses 3Health News:Big Tobacco's Grip on Colleges and Students Loosens, But Still Holding Strong: New Report Examines Trends on Campuses 4
...day night on a bill that would a prescription drug...n // of the politically popular entitlement progra...rs have lined up in our favor," House Speaker Denn...ess conference in the Capitol. "The time is upon u...
...nti-inflammatory drugs (NSAIDs) before and after k... from the procedure.// Researchers from Rush Unive...s who were undergoing knee replacement surgery. So...ned to receive 50 milligrams of an oral NSAID at 2...
...n may be more effective in treating the 14 million... disease that causes persistent redness on the nos...n of azelaic acid gel to the faces of rosacea suff...ercent azelaic acid and is specifically made for r...
...and proponents see it as a promising alternative t...d a lumpectomy.// Thousands of women have already...eek or less of radiation after breast cancer is di... or seven weeks required for whole-breast irradiat...
Other Medicine News:Health News:House heads for Medicare drug vote, 2Health News:House heads for Medicare drug vote, 3Health News:Partial-Breast Irradiation an Unproven Therapy 2
(Date:9/6/2008)... or Greater Concordance Compared to FISH ...ompany to Include Reporting for HER2 Gene Expressi...ts by End of 2008 -, REDWOOD CITY, Calif., Sept. ...Nasdaq: GHDX ) today announced results from two s...or HER2 gene expression, as measured by the,compan...
(Date:9/5/2008)...e-FirstCall/ -- CEL-SCI Corporation,(Amex: CVM ) ...rthritis data,at the Marcus Evans conference on Im...Dr. Daniel Zimmerman, Senior Vice President of Res...at CEL-SCI,s rheumatoid,arthritis vaccine CEL-2000...aused by rheumatoid arthritis in an animal model o...
(Date:9/4/2008)...on for the treatment of Acute Myeloid ...t. 4 /- Celator Pharmaceuticals today...n (FDA) has granted orphan,drug designation to CPX...for the treatment of Acute Myeloid Leukemia (AML)....andomized Phase 2,studies with CPX-351. The first ...
(Date:9/4/2008)...wswire/ -- Southern Research Institute,today annou...has selected,the organization to participate in th...n Center Network (MLPCN). The MLPCN -- a collabora...Libraries Program which is,designed to benefit hum...an,genome and validate future targets for drug dis...
Breaking Medicine Technology:Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients 2Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients 3Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients 4Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients 5Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 2Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 3Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 4Celator Pharmaceuticals Receives Orphan Drug Designation for Anticancer Agent CPX-351 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4New research to help fight widespread potato disease 1140 1New research to help fight widespread potato disease 1140 2Pollution from marine vessels linked to heart and lung disease 1137 1Pollution from marine vessels linked to heart and lung disease 1137 2Symmetry Medical Reports Preliminary Third Quarter Revenue 1716 1Symmetry Medical Reports Preliminary Third Quarter Revenue 1716 2BioSpace Career Fair in Bethesda Maryland Draws Hundreds of Industry Professionals 1713 1BioSpace Career Fair in Bethesda Maryland Draws Hundreds of Industry Professionals 1713 2
...GARY, June 05, 2007 /PRNewswire-FirstCall/ - Oncol...positive results from,its U.S. Phase I clinical tr...SIN(R) in patients with advanced cancers.,The resu...temically,to patients with advanced and metastatic...IN(R) administered as a one-hour infusion on a mon...
...EORTC 18991 Phase III Study Results Presented At A...-term treatment with,pegylated interferon alfa-2b ...ned impact on relapse-free survival (RFS),accordi...er,conducted in patients with stage III melanoma. ...n Organisation for the Research and,Treatment of C...
Other Medicine Technology:Oncolytics Biotech Inc. Announces Positive Clinical Data from U.S.,Phase I REOLYSIN Trial 2Oncolytics Biotech Inc. Announces Positive Clinical Data from U.S.,Phase I REOLYSIN Trial 3Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III,Melanoma Demonstrated Significant and Sustained Impact on,Relapse-Free Survival 2Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III,Melanoma Demonstrated Significant and Sustained Impact on,Relapse-Free Survival 3Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III,Melanoma Demonstrated Significant and Sustained Impact on,Relapse-Free Survival 4Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III,Melanoma Demonstrated Significant and Sustained Impact on,Relapse-Free Survival 5